Latest Blogs

Feb 22, 2018
During a podcast interview on leadership and change, I had the opportunity to discuss how important ASCO is in the life of a cancer doctor.
Feb 22, 2018
Dr. Evgeniya Kharchenko dreamed of creating a local society for young specialists in Russia with ASCO’s values, and made her dream a reality.
Feb 22, 2018
Case-based presentations and tumor board discussions lend additional educational opportunities to this regional conference.
Feb 21, 2018
Dr. Richard L. Schilsky describes ASCO's Targeted Agent and Profiling Utilization Registry (TAPUR) Study and similar independent studies worldwide.
Subscribe to this column

Guest Commentary

Guest Commentary on ASCOconnection.org provides an interactive platform for leaders in their respective fields to share timely perspectives on oncology topics. If you are an ASCO member interested in contributing a guest post, please contact ascoconnection@asco.org.

Jan 24, 2017
In your quest to find healing words for your patients, Dr. Wendy S. Harpham encourages you to attend Saturday's General Session 4: “One of Our Own—Insights of Health Care Providers on Coping with Cancer,” at the 2017 Cancer Survivorship Symposium.
Jan 13, 2017
The inaugural ASCO-SITC Clinical Immuno-Oncology Symposium will have three networking sessions, designed to help physicians determine how immunotherapy best fits into their practice, and to explore career development for newcomers to the field of immunotherapy.
Jan 09, 2017
A highly interactive and personal panel discussion and Q&A session will take place in the evening on January 26, before the official opening of the Cancer Survivorship Symposium in San Diego, CA.
Jan 04, 2017
Attend the 2017 Cancer Survivorship Symposium's Presidents Panel to hear Drs. Wanda Filer, Nitin Damle, and Julie M. Vose discuss how professional societies are workingto meet the needs of their members with respect to the care of cancer survivors.
Dec 19, 2016
This new meeting will focus on the clinical application of immunology to cancer care, including immune checkpoint inhibitor therapy and novel combinations, the use of adoptive T-cell therapy and CAR T-cells, predictive and prognostic biomarkers, and more.
Dec 12, 2016
Dr. Smita Bhatia reflects on Dr. Anna T. Meadows' achievements and contributions to the field of survivorship as the 2017 Cancer Survivorship Symposium approaches.

Pages